2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Mini-Oral Session

[MO33] Mini-Oral Session 33 COVID-19 2

Sat. Feb 19, 2022 3:40 PM - 4:30 PM Room 4 (Room A, 2F, Kyoto International Conference Center)

Chair:Eiki Ichihara(Department of Allergy and Respiratory Medicine, Okayama University),Taiji Koyama(Department of Medical Oncology/Hematology, Kobe University)

[MO33-2] Safety and Immunogenicity of BNT162b2 for Patients Undergoing Chemotherapy for Solid Cancers in Japan

Yohei Funakoshi1, Kimikazu Yakushijin1, Goh Ohji2, Wataru Hojo3, Hironori Sakai3, Ryo Takai4, Taku Nose1, Shinya Ohata1, Yoshiaki Nagatani1, Taiji Koyama1, Akihito Kitao1, Meiko Nishimura1, Yoshinori Imamura1, Naomi Kiyota1,5, Kenichi Harada6, Yugo Tanaka7, Yasuko Mori8, Hironobu Minami1,5 (1.Division of Medical Oncology/Hematology, Department of Medicine, Kobe University Hospital and Graduate School of Medicine, 2.Division of Infection Disease Therapeutics, Department of Microbiology and Infectious Diseases, Kobe University Hospital and Graduate School of Medicine, 3.R&D, Cellspect Co., Ltd., 4.Division of Gastrointestinal Surgery, Department of Surgery, Kobe University Hospital and Graduate School of Medicine, 5.Cancer Center, Kobe University Hospital, 6.Division of Urology, Department of Surgery, Kobe University Hospital and Graduate School of Medicine, 7.Division of Thoracic Surgery, Department of Surgery, Kobe University Hospital and Graduate School of Medicine, 8.Division of Clinical Virology, Center for Infectious Diseases, Kobe University Graduate School of Medicine)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password